SDGR Stock Performance, Insider Transaction and News

SDGR - Schrodinger, Inc.

Market Cap	3.63B	P/E	386.46	EPS this Y	-550.00%	Ern Qtrly Grth	-
Income	-201.46M	Forward P/E	-29.21	EPS next Y	-2.50%	50D Avg Chg	11.00%
Sales	200.63M	PEG	1.81	EPS past 5Y	-	200D Avg Chg	74.00%
Dividend	N/A	Price/Book	5.91	EPS next 5Y	-4.30%	52W High Chg	-15.00%
Recommedations	2.00	Quick Ratio	4.31	Shares Outstanding	63.63M	52W Low Chg	217.00%
Insider Own	2.39%	ROA	-16.83%	Shares Float	62.10M	Beta	1.50
Inst Own	95.16%	ROE	-37.13%	Shares Shorted/Prior	8.76M/8.41M	Price	50.24
Gross Margin	65.50%	Profit Margin	-100.42%	Avg. Volume	1,521,429	Target Price	33.27
Oper. Margin	-111.40%	Earnings Date	Oct 30	Volume	1,546,761	Change	-3.99%

Healthcare | Health Information Services | United States

About Schrodinger, Inc.

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Schrodinger, Inc. News

11/20/24	Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference
11/19/24	Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11/18/24	Schrödinger Broadens and Accelerates Predictive Toxicology Initiative
11/14/24	Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
11/13/24	Schrodinger announces expanded license agreement with Novartis
11/13/24	Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...
11/13/24	Q3 2024 Schrodinger Inc Earnings Call
11/12/24	Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
11/12/24	Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates
11/12/24	Schrödinger Reports Third Quarter 2024 Financial Results
11/12/24	Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis
11/04/24	Schrödinger to Present at Jefferies London Healthcare Conference
10/31/24	Schrödinger to Announce Third Quarter 2024 Financial Results on November 12
06:47 AM	iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?
05:01 AM	Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium
10/09/24	Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium
09/18/24	Schrödinger, Inc. (SDGR): A Bull Case Theory
08/28/24	Schrödinger, Inc. (SDGR): Among The Best Medical AI Companies
08/14/24	Schrödinger to Present at Morgan Stanley Global Healthcare Conference
08/05/24	The 3 Best Med Tech Stocks to Buy Now

SDGR Chatroom

Luka_Brasi Posted - 2 days ago

$SDGR Is Turd, nothing more.

bambus3001 Posted - 2 days ago

$SDGR unentdeckte Perle

glenwoodnate Posted - 4 days ago

$RXRX $SDGR Skills shortage still holding back pharma's digital transformation: survey https://www.fiercepharma.com/marketing/skills-shortage-still-holding-back-pharmas-digital-transformation-survey

longTermAlpha2024 Posted - 5 days ago

$SDGR another good news today but the stock price continued to fall …. Why …

Rybod30 Posted - 5 days ago

$SDGR These guys print $, share price☹️

Rybod30 Posted - 5 days ago

$SDGR Tough to move this…

JimmyBluechips Posted - 1 week ago

$SDGR all new recent gaps have been filled

glenwoodnate Posted - 1 week ago

$RXRX $SDGR $TEM $BEAM $VKTX Well, I guess the only positive thing one could say about the biotech sector is that it's had worse days. I'm still well above my entry points, but that was a pretty brutal sell-off. It makes me wonder whether there are circulating rumors about RFK Jr.

glenwoodnate Posted - 1 week ago

$RXRX $TEM $SDGR

Luka_Brasi Posted - 1 week ago

$SDGR Only thing to be in now is Brain Worm Vaccine, everything else gonna be shut down.

longTermAlpha2024 Posted - 1 week ago

$SDGR battled for so long this morning. Finally got steadily going up

IN0V8 Posted - 1 week ago

$SDGR Opportunity BMO raises target price to $28 from $25

swingingtech Posted - 1 week ago

$DOX $SDGR $WDC https://wallstreetwaves.com/significant-tuesday-options-movements-in-dox-sdgr-and-wdc/

StocksandRealEstate Posted - 1 week ago

@Iliketosleepin Yeahhh maybe so, if not thatd be great but if so, its Ok. I made it up on $SDGR today so it offsets the $-1,200 Im seeing on $AMD

AlSookTraders Posted - 1 week ago

$SDGR in from 21 this morning, let's see if she can give me my 25-30

FarmGuide Posted - 1 week ago

$SDGR Total revenue was $217m last year. Is there any reason why $150m upfront from Novartis isn't significantly positive?

shavitmi Posted - 1 week ago

$SDGR big news with $NVS Schrödinger to receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties. Great AI company that help discover new drugs

Neubaufahrzeug Posted - 1 week ago

$SDGR Maybe little too early, but taking my profit here. Got many turds in my bag to avg down :(

ArcaneMoney Posted - 1 week ago

$SDGR Great premarket interest and move off earnings release. Already moved way outside yesterday's data. I will give it 10-15 min to rotate and settle before looking for a day trade.

shavitmi Posted - 1 week ago

$SDGR acording to the posts here to great news This one is unknown

shavitmi Posted - 1 week ago

$SDGR hope to see 10m shares traded today AI in drug discovery is the future $TSLA Schrödinger to receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties

shavitmi Posted - 1 week ago

$SDGR with novartis $150m they sit on almost $550m in cash More then third of its market cap.

OpenOutcrier Posted - 1 week ago

$SDGR (+14.4% pre) Schrödinger Reports Third Quarter 2024 Financial Results https://ooc.bz/l/47759

shavitmi Posted - 1 week ago

$SDGR if they work with $NVS Schrödinger to receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties. Maybe other big pharma will follow Future is AI also in drug discovery $NVDA

tradingtwenty Posted - 1 week ago

$SDGR has trended 3 times in the past 24 hours (based on 5 minute intervals). Latest press release on Nov 12, 2024 06:45 AM: Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis Link: https://tradingtwenty.com/news/697999/schrdinger-announces-multi-target-collaboration-and-expanded-software-licensing-agreement-with-novartis

shavitmi Posted - 1 week ago

$SDGR 14% shorts I expect a big run

shavitmi Posted - 1 week ago

$SDGR i think this news worth 40% up Lets give market to diagest this news

shavitmi Posted - 1 week ago

$SDGR Schrödinger to receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties

shavitmi Posted - 1 week ago

$SDGR wowwww Big news

Rybod30 Posted - 1 week ago

$SDGR Man, great new on collaboration and no volume🤷‍♂️☹️

Analyst Ratings

Morgan Stanley	Equal-Weight	Aug 21, 24
Keybanc	Overweight	Jul 11, 24
Leerink Partners	Outperform	Jul 2, 24
Citigroup	Buy	May 2, 24
Craig-Hallum	Buy	May 2, 24
Citigroup	Buy	Mar 1, 24
Goldman Sachs	Neutral	Mar 1, 24
Keybanc	Overweight	Feb 29, 24
Citigroup	Buy	Feb 29, 24

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
Herman Jenny	SVP & Controller SVP & Controller	Sep 15	Option	1.20	4,545	5,454	12,548	09/18/23
Tran Yvonne	EVP, CLO & CPO EVP, CLO & CPO	May 22	Sell	37.52	22,960	861,459	12,721	05/24/23
Tran Yvonne	EVP, CLO & CPO EVP, CLO & CPO	May 22	Option	3.92	22,960	90,003	20,681	05/24/23
Lorton Kenneth Patrick	EVP & Chief Technolo.. EVP & Chief Technology Officer	May 23	Sell	40.0587	10,000	400,587	47,388	05/24/23
Thornberry Nancy	Director Director	May 22	Sell	35	14,850	519,750		05/23/23
Thornberry Nancy	Director Director	May 22	Option	11.52	14,850	171,072	14,850	05/23/23
Thornberry Nancy	Director Director	Aug 11	Option	11.52	4,950	57,024	4,950	08/12/22
Thornberry Nancy	Director Director	Aug 11	Sell	35	4,950	173,250		08/12/22
-	- -	Jun 25	Sell	78.28	299,027	23,407,834	6,657,197	06/25/21
-	- -	Jun 23	Sell	76.41	182,948	13,979,057	6,956,224	06/23/21
-	- -	Jun 21	Sell	74.78	165,178	12,352,011	7,139,172	06/21/21
-	- -	Jun 16	Sell	75.36	141,072	10,631,186	7,304,350	06/16/21
-	- -	May 26	Sell	67.2	74,056	4,976,563	7,445,422	05/26/21
-	- -	Apr 21	Sell	72.59	90,000	6,533,100	7,864,405	04/21/21
-	- -	Apr 15	Sell	77.07	120,400	9,279,228	7,954,405	04/15/21
-	- -	Apr 09	Sell	76.03	107,204	8,150,720	8,074,805	04/09/21
-	- -	Apr 01	Sell	75.33	184,043	13,863,959	8,182,009	04/01/21
-	- -	Mar 24	Sell	75.07	150,000	11,260,500	8,366,052	03/24/21
-	- -	Mar 11	Sell	75.27	125,665	9,458,805	8,632,225	03/11/21
Sender Gary	Director Director	Mar 10	Option	11.16	28,775	321,129	28,775	03/10/21
Sender Gary	Director Director	Mar 10	Sell	66.55	28,775	1,914,976		03/10/21
Lorton Kenneth Patrick	EVP & Chief Technolo.. EVP & Chief Technology Officer	Mar 10	Option	10.67	5,836	62,270	53,718	03/10/21
Friesner Richard	Director Director	Mar 10	Sell	67.76	64,000	4,336,640	714,925	03/10/21
Daniel Jennifer	EVP & Chief HR Offic.. EVP & Chief HR Officer	Mar 08	Option	17	836	14,212	7,524	03/08/21
Daniel Jennifer	EVP & Chief HR Offic.. EVP & Chief HR Officer	Mar 08	Sell	74.65	836	62,407	6,688	03/08/21
-	- -	Mar 05	Sell	80.43	100,000	8,043,000	8,757,890	03/05/21
D'Cruz Cony	EVP & Chief Business.. EVP & Chief Business Officer	Mar 05	Option	3.07	2,800	8,596	2,800	03/05/21
D'Cruz Cony	EVP & Chief Business.. EVP & Chief Business Officer	Mar 05	Sell	106.9	4,800	513,120	151,082	03/05/21
Daniel Jennifer	EVP & Chief HR Offic.. EVP & Chief HR Officer	Mar 02	Option	3.71	3,763	13,961	7,106	03/02/21
Daniel Jennifer	EVP & Chief HR Offic.. EVP & Chief HR Officer	Mar 02	Sell	105.78	3,763	398,050	6,688	03/02/21
Daniel Jennifer	SVP & Chief HR Offic.. SVP & Chief HR Officer	Feb 26	Option	3.07	6,689	20,535	10,033	02/26/21
Daniel Jennifer	SVP & Chief HR Offic.. SVP & Chief HR Officer	Feb 26	Sell	110.55	6,689	739,469	6,688	02/26/21
-	- -	Feb 24	Sell	109.57	457,693	50,149,422	8,857,890	02/24/21
Daniel Jennifer	SVP & Chief HR Offic.. SVP & Chief HR Officer	Feb 24	Option	3.07	6,688	20,532	10,032	02/24/21
Daniel Jennifer	SVP & Chief HR Offic.. SVP & Chief HR Officer	Feb 24	Sell	108.96	6,688	728,724	6,688	02/24/21
Tran Yvonne	EVP & Chief Legal Of.. EVP & Chief Legal Officer	Feb 23	Sell	113.55	10,000	1,135,500	17,131	02/23/21
D'Cruz Cony	EVP & Chief Business.. EVP & Chief Business Officer	Feb 22	Option	3.07	2,800	8,596	2,800	02/22/21
D'Cruz Cony	EVP & Chief Business.. EVP & Chief Business Officer	Feb 22	Sell	102	4,800	489,600	153,082	02/22/21
Lebowitz Joel	EVP & CFO EVP & CFO	Feb 17	Option	4.34	5,574	24,191	5,574	02/17/21
Lebowitz Joel	EVP & CFO EVP & CFO	Feb 17	Sell	111.61	5,574	622,114		02/17/21
Lebowitz Joel	EVP & CFO EVP & CFO	Feb 08	Option	17	12,374	210,358	12,374	02/08/21
Lebowitz Joel	EVP & CFO EVP & CFO	Feb 08	Buy	99.9	1,115	111,388		02/08/21
D'Cruz Cony	EVP & Chief Business.. EVP & Chief Business Officer	Feb 04	Option	3.07	2,800	8,596	2,800	02/04/21
D'Cruz Cony	EVP & Chief Business.. EVP & Chief Business Officer	Feb 04	Sell	94.84	4,800	455,232	157,082	02/04/21
Daniel Jennifer	SVP & Chief HR Offic.. SVP & Chief HR Officer	Feb 02	Option	4.34	418	1,814	7,106	02/02/21
Daniel Jennifer	SVP & Chief HR Offic.. SVP & Chief HR Officer	Feb 02	Sell	91.2	418	38,122	6,688	02/02/21
D'Cruz Cony	See Remarks See Remarks	Jan 15	Option	3.07	2,800	8,596	2,800	01/15/21
D'Cruz Cony	See Remarks See Remarks	Jan 15	Sell	89.7	4,800	430,560	161,082	01/15/21
-	- -	Dec 10	Sell	66.84	285,102	19,056,218	9,658,342	12/10/20
-	- -	Dec 04	Sell	65.29	207,239	13,530,634	9,943,444	12/04/20